Downsizing a tumor thrombus of advanced renal cell carcinoma with neoadjuvant systemic therapy and resulting histopathological effects.
Kroeger
N
N
Department of Urology, University Hospital, Jena, Germany. nils.kroeger @ med.uni-jena.de
Gajda
M
M
Zanow
J
J
Petersen
I
I
Settmacher
U
U
Wunderlich
H
H
Steiner
T
T
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness; D009360:Neoplastic Cells, Circulating / Q000187:drug effects* / Q000473:pathology; D009392:Nephrectomy; D011758:Pyrroles / Q000008:administration & dosage*; D000077210:Sunitinib; D017131:Thrombectomy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014682:Vena Cava, Inferior / Q000473:pathology / Q000601:surgery*; D020246:Venous Thrombosis / Q000209:etiology / Q000473:pathology / Q000628:therapy*
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib